Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

City Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs

The Cambridge, Massachusetts company is offering 9.72 million shares at $17 to $19 each and plans to list on Nasdaq under the symbol CTY

City Therapeutics is seeking up to $185 million in a U.S. IPO for its gene-silencing drugs

We haven't written up this one. Quartz has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at qz.com →

More in Finance & Markets

More from Friday 9 October →